Young violinist Katya Tsukanova tragically dies from deadly drug combination

15 July 2019, 16:55 | Updated: July 15, 2019, 19:47

Violinist Katya Tsukanova.

Image: YouTube

A former violinist at the Royal College of Music Junior Department is believed to have died of an overdose of “Calvin Klein”.

Young violinist Katya Tsukanova died from a deadly combination of recreational drugs.

The 17-year-old daughter of Russian bankers and philanthropists, Igor Tsukanov and Natasha Tsukanova, is said to have consumed a mixture of cocaine and ketamine, known as “Calvin Klein”, and is currently making the rounds for the holidays.

Tsukanova’s father found her dead in the family home in Kensington last month, just days after she turned 17 and recently gave a lunchtime recital in the Crush Room at the Royal Opera House.

Talk to The telegraphMr. Tsukanov said: “My daughter was so happy and her future was so bright.

“She was such a smart girl and she made a bad choice. What can we do, we parents? The kids will do whatever they want anyway, and they’ll never tell you the truth.

Violinist Katya Tsukanova

Violinist Katya Tsukanova.

Image: YouTube

Tsukanova was a music teacher at Wycombe Abbey School and studied violin with Zakhar Bron. She was previously in the Junior Department of the Royal College of Music.

“She had just performed at the Royal Opera House and was planning for the future,” her father said. The telegraph. “She even had a painting on the wall of her bedroom with all of her concerts perfectly arranged. Then one morning I walked in and she was lying dead on the floor.

An investigation into the exact cause of his death will take place later this year.

A concert in memory of Tsukanova will take place on August 11 at the Italian festival Suoni dal Golfo, the rhinestone reports.

What is the “Calvin Klein” combination drug?

“Calvin Klein” is the slang name for the combination of cocaine (“Calvin”) and ketamine (“Klein”).

The first is a class A drug and the second is a class B drug, according to the UK government’s drug classification system.

Comments are closed.